Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)
Move your mouse over image or click to enlarge

Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)

Erlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.
Cat# Size Price Qty Buy
A2712-1mg*25 1mg*25
£4,152.00
A2712-1mg*5 1mg*5
£1,384.00
A2712-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2712

Related Documents